Xryliderm (Shoreline Pharmaceuticals, Inc)
Welcome to the PulseAid listing for the Xryliderm drug offered from Shoreline Pharmaceuticals, Inc. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Shoreline Pharmaceuticals, Inc |
NON-PROPRIETARY NAME: | Lidocaine, isopropyl alcohol |
SUBSTANCE NAME: | |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | |
ROUTE: | |
DOSAGE FORM: | KIT |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2016-09-27 |
END MARKETING DATE: | 0000-00-00 |
Xryliderm HUMAN PRESCRIPTION DRUG Details:
Item Description | Xryliderm from Shoreline Pharmaceuticals, Inc |
LABELER NAME: | Shoreline Pharmaceuticals, Inc |
DEA SCHEDULE: | |
ACTIVE STRENGTH: | () |
START MARKETING DATE: | 2016-09-27 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 69621-822_2723c988-3bb5-4b43-95a8-941b034e60e3 |
PRODUCT NDC: | 69621-822 |
APPLICATION NUMBER: | ANDA200675 |